Provexis plc

Research Provexis plc (NZCA) on Bullrun: market cap EUR 23.46M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerNZCA
• ExchangeF
• CountryUnited Kingdom
• SectorHealthcare
• IndustryDrug Manufacturers - Specialty & Generic
• CurrencyEUR
• Market capEUR 23.46M
• Financial periodFY2025
• RevenueEUR 1.29M
• Revenue growth61.1%
• Net income-EUR 452.72K
• Free cash flow-EUR 340.83K
• Gross margin41.2%

Valuation Snapshot

latest market cap is EUR 23.46M.

About Provexis plc

Provexis plc, together with its subsidiaries, develops, licenses, and sells functional foods, medical foods, and dietary supplements worldwide. The company offers syrup and powder versions of Fruitflow, a tomato extract that reduces the propensity for aberrant blood clotting typically associated with cardiovascular diseases, such as heart attack and stroke used in various foods, beverages, and dietary supplement formats. It also provides Fruitflow+ Omega-3, a dietary supplement product.

Frequently asked questions

What is Provexis plc's market cap?

Provexis plc's market capitalization is EUR 23.46M.

What does Provexis plc do?

Provexis plc, together with its subsidiaries, develops, licenses, and sells functional foods, medical foods, and dietary supplements worldwide.